Identification | Back Directory | [Name]
Ticagrelor-d7 | [CAS]
1265911-55-4 | [Synonyms]
Ticagrelor-d7 (1S,2S,3R,5S)- [2H7]-Ticagrelor (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-difluorophenyl)cyclopropylamino)-5-(d7-propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-((propyl-d7)thio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol Ticagrelor D7Q: What is
Ticagrelor D7 Q: What is the CAS Number of
Ticagrelor D7 Q: What is the storage condition of
Ticagrelor D7 Q: What are the applications of
Ticagrelor D7 | [Molecular Formula]
C23H28F2N6O4S | [MDL Number]
MFCD34574639 | [MOL File]
1265911-55-4.mol | [Molecular Weight]
522.568 |
Chemical Properties | Back Directory | [Melting point ]
>125°C (Subl.) | [storage temp. ]
Hygroscopic, Refrigerator, Under inert atmosphere | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
Yellow | [Stability:]
Hygroscopic |
Hazard Information | Back Directory | [Chemical Properties]
Yellow Solid | [Uses]
(Ticagrelor-d7) Labelled Ticagrelor (T437700), the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS)
| [Uses]
Labelled Ticagrelor (T437700), the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS). |
|
Company Name: |
Energy Chemical
|
Tel: |
021-58432009 400-005-6266 |
Website: |
http://www.energy-chemical.com |
|